Published Online
on December 12, 2005

A more recent version of this article appeared on January 1, 2006

This Article Full Text (PDF) All Versions of this Article: 47/1/6    most recent 01.HYP.0000196685.91424.01v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Raizada, M. K. Articles by Sarkissian, S. D. Search for Related Content PubMed PubMed Citation Articles by Raizada, M. K. Articles by Sarkissian, S. D. Pubmed/NCBI databases Medline Plus Health Information Genes and Gene Therapy High Blood Pressure Related Collections ACE/Angiotension receptors Other hypertension Functional genomics Heart failure - basic studies Gene therapy

Submitted on September 28, 2005
Revised on October 7, 2005

Potential of Gene Therapy Strategy for the Treatment of Hypertension

Mohan K. Raizada^* and Shant Der Sarkissian

From the Department of Physiology and Functional Genomics, University of Florida, College of Medicine, Gainesville.

^* To whom correspondence should be addressed. E-mail: mraizada{at}phys.med.ufl.edu.

This article has been cited by other articles:

				Z. Li, C. Yu, Y. Han, H. Ren, W. Shi, C. Fu, D. He, L. Huang, C. Yang, X. Wang, et al. Inhibitory effect of D1-like and D3 dopamine receptors on norepinephrine-induced proliferation in vascular smooth muscle cells Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2761 - H2768. [Abstract] [Full Text] [PDF]

				S. Der Sarkissian, J. L. Grobe, L. Yuan, D. R. Narielwala, G. A. Walter, M. J. Katovich, and M. K. Raizada Cardiac Overexpression of Angiotensin Converting Enzyme 2 Protects the Heart From Ischemia-Induced Pathophysiology Hypertension, March 1, 2008; 51(3): 712 - 718. [Abstract] [Full Text] [PDF]

				C. Zeng, I. Armando, Y. Luo, G. M. Eisner, R. A. Felder, and P. A. Jose Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H551 - H569. [Abstract] [Full Text] [PDF]

				M. Yamazato, Y. Yamazato, C. Sun, C. Diez-Freire, and M. K. Raizada Overexpression of Angiotensin-Converting Enzyme 2 in the Rostral Ventrolateral Medulla Causes Long-Term Decrease in Blood Pressure in the Spontaneously Hypertensive Rats Hypertension, April 1, 2007; 49(4): 926 - 931. [Abstract] [Full Text] [PDF]